Glad to see Merck is still showing up strongly on this screen. The price action is awful – but I feel the company is rock solid – and the yield is also compelling.
| Name | Ticker | Price | Fair Value | Margin of Safety | Yield % | MOS % |
| Amgen Inc | AMGN | $136.53 | $194.00 | $57.47 | 2.15 | 29.62% |
| Merck & Co Inc | MRK | $49.14 | $65.00 | $15.86 | 3.63 | 24.40% |
| Exxon Mobil Corporation | XOM | $72.85 | $92.00 | $19.15 | 3.88 | 20.82% |
| Magellan Midstream Partners, L.P. | MMP | $60.42 | $76.00 | $15.58 | 4.63 | 20.50% |
| Wal-Mart Stores Inc | WMT | $63.59 | $79.00 | $15.41 | 3.06 | 19.51% |
| Spectra Energy Partners LP | SEP | $41.21 | $50.00 | $8.79 | 5.73 | 17.58% |
| Philip Morris International Inc | PM | $79.43 | $92.00 | $12.57 | 4.96 | 13.66% |
| 3M Co | MMM | $138.71 | $160.00 | $21.29 | 2.82 | 13.31% |
| Johnson & Johnson | JNJ | $90.46 | $99.00 | $8.54 | 3.19 | 8.63% |
Based on my own portfolio rules – I need to add more stock to my asset mix, given the sell off and lower valuations – anticipate another options trade soon.
Based on the following screen:
- Stocks to Own Screen:
- Morningstar analysis available.
- Low fair value uncertainty.
- Wide moat.
- Morningstar rating 4 or more stars.
- Financial Health Grade >= B.
- Current P/E <= 20.
Leave a Reply